Developer docs
API playgroundTry for free, no card

Search company profiles

Bluesight

Full company profile

uuid0000de8

Namestring
Bluesight
Legal namestring
Bluesight, Inc.
Websiteurl
bluesight.com
Company typeenum
Private
Founded yearint
2011
Descriptiontext

Bluesight is a medication intelligence company founded in 2011 and headquartered in Alexandria, Virginia, that provides RFID and AI-powered software to 3,000+ hospitals and health systems across the United States and Canada. The company sells a unified suite of six core solutions: KitCheck (RFID-based medication inventory management for kits, trays, and system-wide inventory via KitCheck Anywhere), ControlCheck (drug diversion surveillance, including retail pharmacy), CostCheck (pharmacy purchasing optimization), 340BCheck (340B compliance and self-audit), ShortageCheck (predictive drug shortage management), and PrivacyPro (patient privacy monitoring). The Prism AI Platform, launched in May 2026, layers natural language and generative AI capabilities across the suite, beginning with Prism Assistant inside ControlCheck. The underlying technology combines RFID hardware (tags and scanning stations) with cloud-based software that integrates data from EHRs, automated dispensing cabinets, wholesalers, controlled substance vaults, and HR systems, supported by proprietary behavioral and anomaly detection models and 20+ granted patents.

Bluesight operates a B2B enterprise SaaS business model, with annual subscriptions for software licenses and direct sales of RFID tags as a consumable hardware stream. The company goes to market through a direct enterprise field sales organization targeting pharmacy directors, CFOs, and compliance officers at hospitals and integrated delivery networks, supplemented by group purchasing organization contracts with Premier (national agreement effective May 2026), Vizient, HealthTrust, The Resource Group, and Advantus Health Partners. A direct e-commerce storefront sells KitCheck RFID tags online. Pricing is quote-based, varies by hospital size and module count, and is structured around bundled multi-module contracts with annual billing cycles. The company is private, backed by Thoma Bravo following a July 2023 strategic growth investment that also funded the acquisition of Medacist. Bluesight has since acquired Sectyr (October 2024) for 340B compliance expansion and Protenus (January 2025) for patient privacy capabilities, executing a roll-up strategy in hospital medication intelligence.

The company is led by Co-Founder and CEO Kevin MacDonald, with Mark Peters as CFO, Vijay Venkatesh as CTO, Jason Vander Meer as CPO, and Matt McAluney as CRO. Bluesight has earned 5x Best-in-KLAS recognition for Diversion Monitoring, 6x Best-in-KLAS for Patient Privacy Monitoring, and a MedTech Breakthrough Award, and operates the Bluesight Community across 2,200 hospitals for peer collaboration and product feedback that drives approximately 90% of new feature development.

Short descriptiontext

Bluesight is a medication intelligence company providing RFID and AI-powered software to 3,000+ U.S. and Canadian hospitals for medication inventory tracking, drug diversion surveillance, purchasing optimization, 340B compliance, drug shortage management, and patient privacy monitoring.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersAlexandria, United States
HQ citystring
Alexandria
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
RFID medication management, Drug diversion monitoring, Pharmacy purchasing optimization, 340B compliance software, Patient privacy monitoring
Industry2 codes
PRIMARYHLAFALAL
340B Program Administration & Contract Pharmacy Services
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services
SECONDARYHDADAFAH
Privacy Management (Consent, DSAR, RoPA)
Hardware, Technology & Telecom/Cybersecurity/Data Security & Privacy (DLP, Encryption, Key Mgmt)
NAICS code1 code
  • Software Publishers5132
SIC code2 codes
  • Services-Health Services8000
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
Product category
Hospital Pharmacy Intelligence Software
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1SaaS Subscription — Software Licenses
TypeSubscription Recurring
Description

Bluesight's primary revenue stream is recurring SaaS subscriptions for its suite of hospital intelligence software products (KitCheck, ControlCheck, CostCheck, 340BCheck, ShortageCheck, PrivacyPro). Customers access the platform on a per-subscription basis, with annual renewal cycles. The company markets bundled pricing, offering all six solutions under one vendor with 'bundled savings' and a single annual renewal.

bluesight.com
2RFID Hardware — Tags and Scanning Stations
TypeHardware Sales
Description

Bluesight sells RFID tags (1,000 per roll, with pricing per roll) and provides scanning stations (small, standard, mobile pharmacy cart, KitCheck Anywhere shelf liners) as part of its KitCheck offering. Scanning stations are provided at no cost to contracted customers, while tags are sold directly and through GPO contracts. Tag orders are processed via an order form on the Bluesight website.

bluesight.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Supply Chain
Pricing details1 tier
1Enterprise SaaS subscription with modular product suite — pricing varies by hospital size, number of modules, and contract terms.
ModelSubscriptionBilling cadenceAnnual
Notes

Bluesight offers its full suite of six solutions (KitCheck, ControlCheck, CostCheck, 340BCheck, ShortageCheck, PrivacyPro) under one vendor umbrella with 'bundled savings' and a single annual renewal. Specific per-seat or per-module pricing is not publicly disclosed. The company uses a 'Request a Demo' conversion mechanism consistent with enterprise sales. GPO pricing is available through Premier, Vizient, HealthTrust, and The Resource Group contracts.

bluesight.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 8 records shown
1KitCheck
Description

RFID medication tracking and inventory management solution for hospital kits, trays, and medication tracking

bluesight.com
+7 more records
Core offering1 text field

Bluesight sells a unified suite of hospital intelligence software for U.S. and Canadian hospitals and health systems, anchored by KitCheck (RFID medication tracking for kits, trays, and system-wide inventory), ControlCheck (AI-driven drug diversion surveillance), CostCheck (pharmacy purchasing optimization), 340BCheck (340B compliance and self-auditing), ShortageCheck (predictive drug shortage management), and PrivacyPro (patient privacy monitoring), all powered by the Prism AI platform. The company also sells RFID hardware (tags and scanning stations) and sells primarily through enterprise field sales and group purchasing organization (GPO) contracts with Premier, Vizient, HealthTrust, and others.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • KitCheck delivers 100% accurate restocking, 10x faster than manual processes, and reduces medication waste by up to 92%
+7 more records
Product overview1 text field

Bluesight offers a unified suite of six core hospital intelligence solutions under its Medication Intelligence platform, powered by the Prism AI platform. The portfolio includes: KitCheck (RFID medication tracking for kits, trays, and system-wide inventory via KitCheck Anywhere), ControlCheck (drug diversion surveillance with retail pharmacy module), CostCheck (pharmacy purchasing optimization), 340BCheck (340B compliance management), ShortageCheck (predictive drug shortage management), and PrivacyPro (patient privacy monitoring). These solutions share a common data integration layer that connects fragmented data from wholesalers, health records, dispensing cabinets, and HR systems to provide unified operational visibility across hospital and pharmacy operations.

Product and service8 records
1KitCheck
CategoryRFID Medication Management
Description

Automated RFID-enabled medication management system for hospital kit and tray management, providing 100% accurate restocking 10x faster than manual alternatives. Used by over 1,000 hospitals to prevent medication waste, stockouts, and inaccuracies in OR anesthesia, crash carts, and procedural kits.

2ControlCheck
CategoryDrug Diversion Surveillance
Description

Drug diversion surveillance software providing controlled substance monitoring across nursing, OR, inpatient pharmacy, and retail pharmacy operations. A 5x Best-in-KLAS winner that detects drug diversion 6.6x more effectively than other solutions, using the proprietary IRIS scoring system and closed-loop dose reconciliation that auto-reconciles 95% of controlled substance transactions.

3CostCheck
CategoryPharmacy Purchasing Optimization
Description

Pharmacy cost optimization platform that helps hospitals eliminate approximately 4% of annual drug spend by providing actionable insights and tailored savings opportunities across all classes of trade, with integration to ShortageCheck for supply stability in procurement decisions.

4340BCheck
Category340B Compliance Software
Description

340B compliance software designed as a compliance command center bringing 340B activity and data into one place, providing 100% self-auditing capabilities across patient, provider, and location — not just samples — with workflows designed around HRSA audit requirements and daily OPAIS sync.

5ShortageCheck
CategoryDrug Shortage Management
Description

Drug shortage management software using predictive analytics to forecast supply chain disruptions up to 90 days ahead, combining market intelligence from 3,250+ healthcare organizations (including fulfillment delays, demand surges, and usage trends) with collaborative planning tools for proactive shortage management.

6PrivacyPro
CategoryPatient Privacy Monitoring
Description

Patient privacy monitoring solution that audits up to 100% of system accesses with 95–96% accuracy, using machine learning and Multi-Incident Patient Privacy Cases to detect privacy violations and enable compliance teams to uncover hidden breaches before they escalate. Achieves up to 70% time savings compared to legacy systems. A 6x Best-in-KLAS winner for Patient Privacy Monitoring.

7Prism
CategoryAI Platform for Healthcare
Description

AI platform built specifically for hospital pharmacy and compliance teams. Prism Assistant uses natural language processing to query controlled substance data and behavioral insights, reducing investigative task time by up to 97% (from 30 minutes to under 1 minute for variance analysis) and generating structured, evidence-backed answers in under 60 seconds.

8KitCheck RFID Tags and Scanning Stations
CategoryRFID Hardware
Description

RFID tags (1,000 per roll) sold directly to hospitals via the Bluesight website order form and through GPO purchasing channels, along with RFID scanning stations (small, standard, mobile pharmacy cart, and KitCheck Anywhere shelf-liners) provided as part of the KitCheck offering. Scanning stations are provided at no cost to contracted customers; tags are sold directly with standard, two-day, or overnight shipping.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-06-10
Description

Bluesight was awarded a national group purchasing agreement with Premier, Inc. for Pharmacy Technology Solutions, effective May 1, 2026. Premier members can access Bluesight's full suite of solutions—including drug diversion surveillance, purchasing optimization, 340B compliance, shortage management, RFID inventory management, and patient privacy monitoring—at pre-negotiated pricing. This formalizes and expands a relationship spanning more than a decade.

Strategic tierStrategicTypeTechnology or IntegrationAnnounced on2026-03-03
Description

Bluesight announced a strategic partnership with GraphiteRx to integrate marketplace data—including Mark Cuban Cost Plus Drugs pricing—into Bluesight's hospital procurement tools (CostCheck and ShortageCheck). This integration helps hospitals reduce drug costs and manage shortages by expanding access to alternative medication sources.

3Pharmaceutical Logistics Companies
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-12-02
Description

Bluesight announced strategic collaborations with pharmaceutical logistics and manufacturers at the 2025 ASHP Midyear Clinical Meeting to improve pharmacy operations and compliance, following a year of record growth, strategic partnerships, and product innovation.

prnewswire.com
Strategic tierStrategicTypeTechnology or Integration
Description

NXP Semiconductors collaborates with Bluesight (Kit Check deployed in over 900 U.S. hospitals) along with other healthcare ecosystem partners to deploy RFID and NFC technologies for patient safety, inventory management, and item-level traceability. NXP's RAIN RFID and NFC technologies enable bulk reading of medical supplies at speeds exceeding 1,000 items per second with 99.9% accuracy.

Strategic tierStrategicTypeTechnology or Integration
Description

Bluesight has partnered with 503B outsourcing facilities and pharmaceutical manufacturers to offer pre-tagged RFID medications that scan right out of the box. Partners include Fagron, Leiters, Nephron 503B Outsourcing Facility, QuVa, SCA Pharma, and Wells Pharma. This enables hospitals to use RFID-tagged medications without in-house tagging, reducing implementation friction for KitCheck.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Surescripts operates the dominant U.S. health information network for prescriptions, providing clinical intelligence, benefit transparency, and medication-related data services to hospitals and pharmacies. Its network breadth and clinical data assets are comparable to Bluesight's hospital intelligence data layer.

TypeDirect peer
Description

symplr is a healthcare governance, risk, and compliance platform offering provider credentialing, contract management, and 340B-related solutions — directly overlapping with Bluesight's 340BCheck and broader compliance suite. Both sell multi-module compliance software to hospital systems and IDNs.

3McKesson Corporation
TypeBroad incumbent
Description

McKesson is a major drug distributor and healthcare IT provider whose pharmacy services and analytics offerings (including its US Oncology/Prescription Technology Solutions business) overlap with Bluesight's CostCheck purchasing optimization and ShortageCheck drug shortage products.

TypeDirect peer
Description

Omnicell is a leading provider of medication management and pharmacy automation solutions for hospitals, directly competing with Bluesight in RFID-enabled kit/tray management, controlled substance tracking, and pharmacy analytics. Both serve the same acute-care pharmacy buyer with overlapping drug diversion and inventory capabilities.

TypeBroad incumbent
Description

Cardinal Health is a top-tier pharmaceutical distributor with a portfolio that includes hospital pharmacy solutions, inventory management, and 340B services (through its Cordavis biosimilar venture and consulting). It is a partial competitor and partner in Bluesight's drug purchasing ecosystem.

TypeBroad incumbent
Description

BD's Medical and Pharmaceutical Systems segments supply medication management solutions including automated dispensing cabinets, pharmacy workflow software, and drug tracking hardware. BD overlaps with Bluesight in hospital medication inventory and controlled substance management, but as part of a much broader med-tech portfolio.

TypeBroad incumbent
Description

Cencora is one of the largest U.S. pharmaceutical distributors and offers hospital pharmacy services and data/analytics tools. Its World Courier, consulting, and biopharma services businesses intersect with Bluesight's drug procurement and shortage management offerings, though Cencora's reach is much broader.

TypeDirect peer
Description

Imprivata provides identity, access management, and patient privacy monitoring solutions to hospitals, directly competing with Bluesight's PrivacyPro in healthcare privacy surveillance and access auditing. Both target healthcare compliance teams with ML-driven monitoring of EHR access events.

TypeDirect peer
Description

Macro Helix is a specialized provider of 340B compliance, split-billing, and pharmacy management software, directly competing with Bluesight's 340BCheck module. Both serve the same HRSA-audit-driven buyer at hospitals and contract pharmacies.

TypeEmerging player
Description

Veeva is a leading vertical SaaS provider in life sciences and increasingly in healthcare, with Vault applications covering compliance, quality, and data management. While primarily life-sciences-focused, Veeva's compliance and quality suite serves a comparable hospital compliance buyer profile and represents a benchmark for vertical SaaS expansion playbooks.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration8 records

Each record includes

Title, Type, Description, Source

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors17 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bluesight

Hospital Pharmacy Intelligence Softwarebluesight.com

Bluesight is a medication intelligence company providing RFID and AI-powered software to 3,000+ U.S. and Canadian hospitals for medication inventory tracking, drug diversion surveillance, purchasing optimization, 340B compliance, drug shortage management, and patient privacy monitoring.

What Bluesight does

Bluesight is a medication intelligence company founded in 2011 and headquartered in Alexandria, Virginia, that provides RFID and AI-powered software to 3,000+ hospitals and health systems across the United States and Canada. The company sells a unified suite of six core solutions: KitCheck (RFID-based medication inventory management for kits, trays, and system-wide inventory via KitCheck Anywhere), ControlCheck (drug diversion surveillance, including retail pharmacy), CostCheck (pharmacy purchasing optimization), 340BCheck (340B compliance and self-audit), ShortageCheck (predictive drug shortage management), and PrivacyPro (patient privacy monitoring). The Prism AI Platform, launched in May 2026, layers natural language and generative AI capabilities across the suite, beginning with Prism Assistant inside ControlCheck. The underlying technology combines RFID hardware (tags and scanning stations) with cloud-based software that integrates data from EHRs, automated dispensing cabinets, wholesalers, controlled substance vaults, and HR systems, supported by proprietary behavioral and anomaly detection models and 20+ granted patents.

Bluesight operates a B2B enterprise SaaS business model, with annual subscriptions for software licenses and direct sales of RFID tags as a consumable hardware stream. The company goes to market through a direct enterprise field sales organization targeting pharmacy directors, CFOs, and compliance officers at hospitals and integrated delivery networks, supplemented by group purchasing organization contracts with Premier (national agreement effective May 2026), Vizient, HealthTrust, The Resource Group, and Advantus Health Partners. A direct e-commerce storefront sells KitCheck RFID tags online. Pricing is quote-based, varies by hospital size and module count, and is structured around bundled multi-module contracts with annual billing cycles. The company is private, backed by Thoma Bravo following a July 2023 strategic growth investment that also funded the acquisition of Medacist. Bluesight has since acquired Sectyr (October 2024) for 340B compliance expansion and Protenus (January 2025) for patient privacy capabilities, executing a roll-up strategy in hospital medication intelligence.

The company is led by Co-Founder and CEO Kevin MacDonald, with Mark Peters as CFO, Vijay Venkatesh as CTO, Jason Vander Meer as CPO, and Matt McAluney as CRO. Bluesight has earned 5x Best-in-KLAS recognition for Diversion Monitoring, 6x Best-in-KLAS for Patient Privacy Monitoring, and a MedTech Breakthrough Award, and operates the Bluesight Community across 2,200 hospitals for peer collaboration and product feedback that drives approximately 90% of new feature development.

Bluesight firmographics

Firmographics
Name
Bluesight
Legal name
Bluesight, Inc.
Website
https://bluesight.com
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
51–100 employees
Short description
Bluesight is a medication intelligence company providing RFID and AI-powered software to 3,000+ U.S. and Canadian hospitals for medication inventory tracking, drug diversion surveillance, purchasing optimization, 340B compliance, drug shortage management, and patient privacy monitoring.
Ownership category
akta.pro rank

Bluesight industry classification

Industry
Product category
Hospital Pharmacy Intelligence Software
NAICS
Software Publishers (5132)
SIC
Services-Health Services (8000), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
akta.pro industry
PRIMARYHLAFALAL
340B Program Administration & Contract Pharmacy Services
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services
SECONDARYHDADAFAH
Privacy Management (Consent, DSAR, RoPA)
Hardware, Technology & Telecom/Cybersecurity/Data Security & Privacy (DLP, Encryption, Key Mgmt)

Keywords

  • RFID medication management
  • Drug diversion monitoring
  • Pharmacy purchasing optimization
  • 340B compliance software
  • Patient privacy monitoring

Where Bluesight is headquartered

Location

Headquarters

HQ city
Alexandria
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Bluesight business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Supply Chain

Revenue model

  1. SaaS Subscription — Software Licenses: Bluesight's primary revenue stream is recurring SaaS subscriptions for its suite of hospital intelligence software products (KitCheck, ControlCheck, CostCheck, 340BCheck, ShortageCheck, PrivacyPro). Customers access the platform on a per-subscription basis, with annual renewal cycles. The company markets bundled pricing, offering all six solutions under one vendor with 'bundled savings' and a single annual renewal.
  2. RFID Hardware — Tags and Scanning Stations: Bluesight sells RFID tags (1,000 per roll, with pricing per roll) and provides scanning stations (small, standard, mobile pharmacy cart, KitCheck Anywhere shelf liners) as part of its KitCheck offering. Scanning stations are provided at no cost to contracted customers, while tags are sold directly and through GPO contracts. Tag orders are processed via an order form on the Bluesight website.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise SaaS subscription with modular product suite — pricing varies by hospital size, number of modules, and contract terms.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Bluesight product offering

Product offering

Core offering

Bluesight sells a unified suite of hospital intelligence software for U.S. and Canadian hospitals and health systems, anchored by KitCheck (RFID medication tracking for kits, trays, and system-wide inventory), ControlCheck (AI-driven drug diversion surveillance), CostCheck (pharmacy purchasing optimization), 340BCheck (340B compliance and self-auditing), ShortageCheck (predictive drug shortage management), and PrivacyPro (patient privacy monitoring), all powered by the Prism AI platform. The company also sells RFID hardware (tags and scanning stations) and sells primarily through enterprise field sales and group purchasing organization (GPO) contracts with Premier, Vizient, HealthTrust, and others.

Product overview

Bluesight offers a unified suite of six core hospital intelligence solutions under its Medication Intelligence platform, powered by the Prism AI platform. The portfolio includes: KitCheck (RFID medication tracking for kits, trays, and system-wide inventory via KitCheck Anywhere), ControlCheck (drug diversion surveillance with retail pharmacy module), CostCheck (pharmacy purchasing optimization), 340BCheck (340B compliance management), ShortageCheck (predictive drug shortage management), and PrivacyPro (patient privacy monitoring). These solutions share a common data integration layer that connects fragmented data from wholesalers, health records, dispensing cabinets, and HR systems to provide unified operational visibility across hospital and pharmacy operations.

Differentiator

Problem solved

Functional benefit

Brands

  • KitCheck: RFID medication tracking and inventory management solution for hospital kits, trays, and medication tracking
  • ControlCheck
  • CostCheck
  • 340BCheck
  • ShortageCheck
  • PrivacyPro
  • Prism
  • KitCheck Anywhere

Products and services

  • KitCheck Automated RFID-enabled medication management system for hospital kit and tray management, providing 100% accurate restocking 10x faster than manual alternatives. Used by over 1,000 hospitals to prevent medication waste, stockouts, and inaccuracies in OR anesthesia, crash carts, and procedural kits.
  • ControlCheck Drug diversion surveillance software providing controlled substance monitoring across nursing, OR, inpatient pharmacy, and retail pharmacy operations. A 5x Best-in-KLAS winner that detects drug diversion 6.6x more effectively than other solutions, using the proprietary IRIS scoring system and closed-loop dose reconciliation that auto-reconciles 95% of controlled substance transactions.
  • CostCheck Pharmacy cost optimization platform that helps hospitals eliminate approximately 4% of annual drug spend by providing actionable insights and tailored savings opportunities across all classes of trade, with integration to ShortageCheck for supply stability in procurement decisions.
  • 340BCheck 340B compliance software designed as a compliance command center bringing 340B activity and data into one place, providing 100% self-auditing capabilities across patient, provider, and location — not just samples — with workflows designed around HRSA audit requirements and daily OPAIS sync.
  • ShortageCheck Drug shortage management software using predictive analytics to forecast supply chain disruptions up to 90 days ahead, combining market intelligence from 3,250+ healthcare organizations (including fulfillment delays, demand surges, and usage trends) with collaborative planning tools for proactive shortage management.
  • PrivacyPro Patient privacy monitoring solution that audits up to 100% of system accesses with 95–96% accuracy, using machine learning and Multi-Incident Patient Privacy Cases to detect privacy violations and enable compliance teams to uncover hidden breaches before they escalate. Achieves up to 70% time savings compared to legacy systems. A 6x Best-in-KLAS winner for Patient Privacy Monitoring.
  • Prism AI platform built specifically for hospital pharmacy and compliance teams. Prism Assistant uses natural language processing to query controlled substance data and behavioral insights, reducing investigative task time by up to 97% (from 30 minutes to under 1 minute for variance analysis) and generating structured, evidence-backed answers in under 60 seconds.
  • KitCheck RFID Tags and Scanning Stations RFID tags (1,000 per roll) sold directly to hospitals via the Bluesight website order form and through GPO purchasing channels, along with RFID scanning stations (small, standard, mobile pharmacy cart, and KitCheck Anywhere shelf-liners) provided as part of the KitCheck offering. Scanning stations are provided at no cost to contracted customers; tags are sold directly with standard, two-day, or overnight shipping.

Quantifiable outcome

  • KitCheck delivers 100% accurate restocking, 10x faster than manual processes, and reduces medication waste by up to 92%
  • +7 more outcomes

Companies that use Bluesight

Customer profile

Named customers8 records

Segments1 record

Ideal customer profiles1 record

Bluesight technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration8 records

AI capability9 records

Feature7 records

Bluesight partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core, strategic and minor.

  • Premier, Inc.coreChannel Partner/ Reseller/ Distributor · 10 June 2026Bluesight was awarded a national group purchasing agreement with Premier, Inc. for Pharmacy Technology Solutions, effective May 1, 2026. Premier members can access Bluesight's full suite of solutions—including drug diversion surveillance, purchasing optimization, 340B compliance, shortage management, RFID inventory management, and patient privacy monitoring—at pre-negotiated pricing. This formalizes and expands a relationship spanning more than a decade.
  • GraphiteRxstrategicTechnology or Integration · 3 March 2026Bluesight announced a strategic partnership with GraphiteRx to integrate marketplace data—including Mark Cuban Cost Plus Drugs pricing—into Bluesight's hospital procurement tools (CostCheck and ShortageCheck). This integration helps hospitals reduce drug costs and manage shortages by expanding access to alternative medication sources.
  • Pharmaceutical Logistics CompaniesminorStrategic or Co-development Partner · 2 December 2025Bluesight announced strategic collaborations with pharmaceutical logistics and manufacturers at the 2025 ASHP Midyear Clinical Meeting to improve pharmacy operations and compliance, following a year of record growth, strategic partnerships, and product innovation.
  • NXP SemiconductorsstrategicTechnology or IntegrationNXP Semiconductors collaborates with Bluesight (Kit Check deployed in over 900 U.S. hospitals) along with other healthcare ecosystem partners to deploy RFID and NFC technologies for patient safety, inventory management, and item-level traceability. NXP's RAIN RFID and NFC technologies enable bulk reading of medical supplies at speeds exceeding 1,000 items per second with 99.9% accuracy.
  • 503B Outsourcing Facilities & Pharmaceutical Manufacturers (KitCheck Tagging Partners)strategicTechnology or IntegrationBluesight has partnered with 503B outsourcing facilities and pharmaceutical manufacturers to offer pre-tagged RFID medications that scan right out of the box. Partners include Fagron, Leiters, Nephron 503B Outsourcing Facility, QuVa, SCA Pharma, and Wells Pharma. This enables hospitals to use RFID-tagged medications without in-house tagging, reducing implementation friction for KitCheck.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Bluesight competitors and assessment

Company assessment

Direct peers

  • Surescripts: Surescripts operates the dominant U.S. health information network for prescriptions, providing clinical intelligence, benefit transparency, and medication-related data services to hospitals and pharmacies. Its network breadth and clinical data assets are comparable to Bluesight's hospital intelligence data layer.
  • symplr: symplr is a healthcare governance, risk, and compliance platform offering provider credentialing, contract management, and 340B-related solutions — directly overlapping with Bluesight's 340BCheck and broader compliance suite. Both sell multi-module compliance software to hospital systems and IDNs.
  • Omnicell: Omnicell is a leading provider of medication management and pharmacy automation solutions for hospitals, directly competing with Bluesight in RFID-enabled kit/tray management, controlled substance tracking, and pharmacy analytics. Both serve the same acute-care pharmacy buyer with overlapping drug diversion and inventory capabilities.
  • Imprivata: Imprivata provides identity, access management, and patient privacy monitoring solutions to hospitals, directly competing with Bluesight's PrivacyPro in healthcare privacy surveillance and access auditing. Both target healthcare compliance teams with ML-driven monitoring of EHR access events.
  • Macro Helix: Macro Helix is a specialized provider of 340B compliance, split-billing, and pharmacy management software, directly competing with Bluesight's 340BCheck module. Both serve the same HRSA-audit-driven buyer at hospitals and contract pharmacies.

Broad incumbents

  • McKesson Corporation: McKesson is a major drug distributor and healthcare IT provider whose pharmacy services and analytics offerings (including its US Oncology/Prescription Technology Solutions business) overlap with Bluesight's CostCheck purchasing optimization and ShortageCheck drug shortage products.
  • Cardinal Health: Cardinal Health is a top-tier pharmaceutical distributor with a portfolio that includes hospital pharmacy solutions, inventory management, and 340B services (through its Cordavis biosimilar venture and consulting). It is a partial competitor and partner in Bluesight's drug purchasing ecosystem.
  • Becton, Dickinson and Company (BD): BD's Medical and Pharmaceutical Systems segments supply medication management solutions including automated dispensing cabinets, pharmacy workflow software, and drug tracking hardware. BD overlaps with Bluesight in hospital medication inventory and controlled substance management, but as part of a much broader med-tech portfolio.
  • Cencora (formerly AmerisourceBergen): Cencora is one of the largest U.S. pharmaceutical distributors and offers hospital pharmacy services and data/analytics tools. Its World Courier, consulting, and biopharma services businesses intersect with Bluesight's drug procurement and shortage management offerings, though Cencora's reach is much broader.

Emerging players

  • Veeva Systems: Veeva is a leading vertical SaaS provider in life sciences and increasingly in healthcare, with Vault applications covering compliance, quality, and data management. While primarily life-sciences-focused, Veeva's compliance and quality suite serves a comparable hospital compliance buyer profile and represents a benchmark for vertical SaaS expansion playbooks.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Bluesight social profiles

Digital presence

Bluesight compliance and trust

Trust signal

Compliance1 record

Bluesight financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bluesight leadership team

Management profile

Number of profiles

Profiles10 records

Bluesight subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Bluesight funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors17 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bluesight M&A and investment

M&A and investment

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bluesight

What does Bluesight do?

Bluesight sells a unified suite of hospital intelligence software for U.S. and Canadian hospitals and health systems, anchored by KitCheck (RFID medication tracking for kits, trays, and system-wide inventory), ControlCheck (AI-driven drug diversion surveillance), CostCheck (pharmacy purchasing optimization), 340BCheck (340B compliance and self-auditing), ShortageCheck (predictive drug shortage management), and PrivacyPro (patient privacy monitoring), all powered by the Prism AI platform. The company also sells RFID hardware (tags and scanning stations) and sells primarily through enterprise field sales and group purchasing organization (GPO) contracts with Premier, Vizient, HealthTrust, and others.

Is Bluesight a public or private company?

Bluesight is a private company. It is classified as private equity controlled and is currently operating.

When was Bluesight founded?

Bluesight was founded in 2011. It employs 51 to 100 people.

Where is Bluesight based?

Bluesight is headquartered in Alexandria, United States, in the North America region.

How does Bluesight make money?

Two revenue lines are on record. SaaS Subscription — Software Licenses are the primary driver. The others are RFID Hardware — Tags and Scanning Stations.

Who are Bluesight's main competitors?

Direct peers on record are Surescripts, symplr, Omnicell, Imprivata and Macro Helix. Broad incumbents are McKesson Corporation, Cardinal Health, Becton, Dickinson and Company (BD) and Cencora (formerly AmerisourceBergen). Veeva Systems is listed as an emerging player.

Does Bluesight have an API?

No public API is recorded for Bluesight.

What industry is Bluesight in?

Bluesight's product category is Hospital Pharmacy Intelligence Software. Its primary akta.pro industry code is HLAFALAL, 340B Program Administration & Contract Pharmacy Services, with a secondary code of HDADAFAH, Privacy Management (Consent, DSAR, RoPA). Its NAICS code is 5132 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MedCity NewsHealthcare Privacy Leaders Look to AI to Improve Monitoring and Data Breach InvestigationsHealthcare privacy leaders discussed using AI to automate monitoring and investigate data breaches at a Bluesight symposium. A 2025 Bluesight report cited over 300 million patient records compromised in 2024, a 26% increase from 2023. Speakers emphasized the need for human oversight and case-specific investigation.GlobeNewswireBluesight Launches Revenue Optimization Capabilities, Expanding Margin Insights for Hospital PharmaciesBluesight announced Medicare Revenue Optimizer, a new CostCheck capability that factors in Medicare Part B reimbursement data to show cost and margin impact. The platform, used by over 500 hospitals, has helped improve margins by 1-9% of annual drug expenditures. A Claims-Based Revenue Optimizer is planned for later in 2026.GlobeNewswireBluesight Launches Revenue Optimization Capabilities, Expanding Margin Insights for Hospital PharmaciesBluesight, a hospital intelligence solutions company, announced Medicare Revenue Optimizer, a new capability within its CostCheck platform used by over 500 U.S. hospitals to analyze drug procurement.BenzingaBluesight Launches Revenue Optimization Capabilities, Expanding Margin Insights for Hospital PharmaciesBluesight announced Medicare Revenue Optimizer, a new CostCheck capability that factors in Medicare Part B reimbursement data to show cost and margin impact for separately reimbursable drugs. The platform, used by over 500 hospitals, has helped improve margins by 1-9% of annual drug expenditures. A Claims-Based Revenue Optimizer preview is planned for later in 2026.HIT ConsultantBluesight Partners with Pfizer to Integrate SmartDose™ Source-Tagged Medications into KitCheckBluesight has partnered with Pfizer Global Hospital & Biosimilars to integrate Pfizer's SmartDose™ RFID-enabled medications into Bluesight's KitCheck hospital inventory management platform, shifting RFID tagging upstream to the point of manufacture. SmartDose™ represents an industry first by using automated readback verification for each individual vial during production to ensure encoding accuracy and tag integrity before release. The source-tagged Pfizer SmartDose™ portfolio is projected to be commercially available for hospital purchase in the second half of 2026.GlobeNewswireBluesight and Pfizer Partner to Provide Source-Tagged RFID Medications to Hospital PharmaciesBluesight has partnered with Pfizer Global Hospital & Biosimilars to integrate SmartDose RFID-enabled medications with the KitCheck inventory management platform, allowing hospitals to receive medications pre-tagged, encoded, and pre-associated at the point of manufacture. The partnership moves RFID tagging upstream from hospitals to the manufacturing stage, reducing manual tagging labor while maintaining inventory management efficiency, patient safety, and regulatory compliance benefits. Pfizer SmartDose medications are projected to be available for purchase in the second half of 2026, with an estimated one-third of U.S. hospitals already using RFID technology for medication management.BenzingaBluesight and Pfizer Partner to Provide Source-Tagged RFID Medications to Hospital PharmaciesPfizer and Bluesight announced a partnership to integrate SmartDose RFID-enabled medications with the KitCheck inventory platform, delivering pre-tagged, pre-associated medications to hospital pharmacies. The partnership aims to reduce manual tagging labor, with SmartDose projected to be available for purchase in the second half of 2026.BioSpaceBluesight and Pfizer Partner to Provide Source-Tagged RFID Medications to Hospital PharmaciesBluesight and Pfizer announced a partnership to integrate SmartDose RFID-enabled medications with the KitCheck inventory platform, delivering pre-tagged, pre-associated drugs at the point of manufacture. The collaboration aims to reduce manual tagging labor, with SmartDose projected available for purchase in the second half of 2026.Amazon Web ServicesBuilding an agentic AI solution at Bluesight with Amazon BedrockBluesight launched Prism Assistant, an agentic AI solution built on Amazon Bedrock AgentCore, to automate complex healthcare compliance workflows for its hospital clients. The system utilizes multi-agent orchestration to analyze data across multiple Bluesight products, significantly reducing the manual time required for tasks like drug diversion detection and GPO prohibition auditing.GlobeNewswireBluesight Awarded Pharmacy Technology Solutions Agreement with Premier, Inc.Bluesight, a hospital intelligence solutions provider, has been awarded a national group purchasing agreement with Premier, Inc. for Pharmacy Technology Solutions, effective May 1. The agreement allows Premier's member healthcare organizations to access Bluesight's full suite of solutions—including drug diversion surveillance, purchasing optimization, 340B compliance, shortage management, RFID inventory management, and patient privacy monitoring—at pre-negotiated pricing. This agreement marks a significant evolution in the decade-long relationship between the two companies, formalizing what began as a focused collaboration into a comprehensive strategic partnership granting Premier members unified access to Bluesight's complete portfolio.